Clinical multidrug resistance in cancer: A multifactorial problem
- 30 June 1996
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (6) , 912-920
- https://doi.org/10.1016/0959-8049(96)00069-x
Abstract
No abstract availableThis publication has 61 references indexed in Scilit:
- Multidrug resistance in breast cancer: Mechanisms, strategiesEuropean Journal Of Cancer, 1995
- Modulation of the Organ Microenvironment for Treatment of Cancer MetastasisJNCI Journal of the National Cancer Institute, 1995
- Drug Resistance-Associated Marker Lrp for Prediction of Response to Chemotherapy and Prognoses in Advanced Ovarian CarcinomaJNCI Journal of the National Cancer Institute, 1995
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Parallel assessment of glutathione-based detoxifying enzymes, O6-alkylguanine-dna alkyltransferase and P-glycoprotein as indicators of drug resistance in tumor and normal lung of patients with lung cancerInternational Journal of Cancer, 1994
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- Genetic Differences in Drug DispositionThe Journal of Clinical Pharmacology, 1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein 170, and glutathione S-transf erase-π in human lung tumorsCancer, 1992
- Upregulation of O6-alkylguanine-DNA-alkyltransferase expression and the presence of double minute chromosomes in alkylating agent selected Chinese hamster cellsCarcinogenesis: Integrative Cancer Research, 1992